Avid Bioservices Inc (CDMO): Hello all, The following post came fr...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	7
Posts	255
Boards Moderated	0
Alias Born	03/07/2004

mmignot

Re: entdoc post# 58094

Saturday, 11/06/2010 6:57:57 PM

Saturday, November 06, 2010 6:57:57 PM

Hello all,

The following post came from Terry D. on the Silicon Investor site. It looks like Medibiotech is projecting revenue from sales of Vivatuxin in 2011-2013. Does this mean that we should see revenue from our agreement with Cancer Therapeutics (Epstein)?

M :)

http://siliconinvestor.advfn.com/readmsg.aspx?msgid=26931334

I just noticed this from the link on Medibiotech.

FINANCIAL STATEMENT HIGHLIGHTS
MediPharm plans to invest in Radiation-Protective Facilities
(RPFs) in 150 China Tier 3 hospitals, with each
hospital requiring investment of $75,000 for a total of
$11.3 million.
Vivatuxin® is expected to generate
$45.1 million revenue and $13.8 million net profit in 2011,

$92.8 million revenue and $36.1 million net profit in 2012,

and $143.3 million revenue and $52.1 million net
profit in 2013.

FINANCIAL PROJECTIONS
All figures for twelve months ended December 31, 2009

Look on the right
http://www.wallstreetresearch.org/reports/profile_medipharm.pdf